TickerFacts.

Eupraxia Pharmaceuticals Inc. (EPRX): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

39.96M
Year ended 2025-12-31
+27.5%
3-year compound annual growth
2022-12-31: 19.29M2023-12-31: 24.15M2024-12-31: 33.93M2025-12-31: 39.96M39.96M
2022-12-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-3139.96M+17.8%2026-03-13, From 2025-01-01
2024-12-3133.93M+40.5%2026-03-13, From 2024-01-01
2023-12-3124.15M+25.2%2025-03-20, From 2023-01-01
2022-12-3119.29Mn/a2024-04-01, From 2022-01-01